COVID-19 Impact on Pharmaceutical Packaging in Chemicals and Materials Industry

AI Reveals Drugs That May Help Combating Alzheimer Disease

  • Uncategorized
  • Apr 23, 2021

Technology and healthcare go side by side and to extract the most out of healthcare by giving a relevant solution, technology is a must-try. Based on artificial intelligence there are a lot of things running on their own. The Decision-making process is very crucial to complete a particular task. Researchers have successfully developed this special kind of methodology which is helpful for identification of problems and critical situation which are not being analyzed by an expert or doctor. This whole method is based on an artificial intelligence, the reaction of this process is rapid, it also identifies currently present medication and how it might treat Alzheimer's disease. Many industries and hospitals are using this process of artificial intelligence. The method also reveals the true potential of a new treatment that targets this disease. In today’s era, a new treatment for Alzheimer's disease is desperately needed and the number of individuals suffering from this disease is high and there is no guaranteed cure for it. Since, numerous clinical trials of investigating drugs have failed to generate promising solutions; it can lead to some serious trouble.

A team at Massachusetts General Hospital (MGH) and Harvard Medical School (HMS) have recently developed a brand new technology with the help of artificial intelligence. To screen the currently present medicine, the method is most frequently used for the treatment of Alzheimer's disease. For the progressive purpose, this method has the potential to represent a rapid and inexpensive way to get treated, thus, the treatment can prove to be effective. 

Neurodegenerative conditions are worse in some cases and most importantly if you see it minutely, it could help reveal new, unexplored targets for conducting a potential therapy. This way, new targets can be achieved. If FDA approves few drugs, it would be beneficial to the patients. Also, it is known that clinical trial requires substantial resources but unfortunately for previously approved drugs these automated tools were not introduced and hence, sometimes it becomes an impossible task to evaluate every drug present to treat Alzheimer.